Dems, Multiple Sclerosis Activists Target High Drug Prices

Legislators and the National Multiple Sclerosis Society have launched separate efforts to investigate rising drug costs for multiple sclerosis.

According to the NMSS, MS therapies saw spike to $78,000 from $16,000 between 2004 and 2016.

Click here to read more on Gears of Biz.

You might also be interested in:

Activists Flock to PhRMA HQ April 30, 2019
ICER’s Updated Assessment of New Targeted Therapies for… June 13, 2018
Report: Price Increases Main Driver of Rising Drug Costs January 8, 2019
Pharmacy Benefit Managers: A Mechanism for Containing Costs or… October 1, 2018
Drugmakers Raise Prices to Start 2019 January 2, 2019
PBMs: Drugmakers to Blame for High Drug Costs August 16, 2018
Health Prices Varied Across U.S., According to HCCI October 29, 2018